cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study

Clinical trial NCT03243604 · COMPLETED

Trial details

NCT number: NCT03243604
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Arrhythmias, Cardiac Atrial Fibrillation and Flutter Tachycardia, Supraventricular Cardiac Failure

Start date: 2017-05-16
Primary completion: 2017-07-13
Enrollment: 1717

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.